Nova EYE Medical Ltd (EYE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nova EYE Medical Ltd (EYE) has a cash flow conversion efficiency ratio of -0.144x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.28 Million ≈ $-1.61 Million USD) by net assets (AU$15.82 Million ≈ $11.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nova EYE Medical Ltd - Cash Flow Conversion Efficiency Trend (1992–2025)
This chart illustrates how Nova EYE Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EYE liabilities breakdown for a breakdown of total debt and financial obligations.
Nova EYE Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nova EYE Medical Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Newtree Co.Ltd
KQ:270870
|
0.021x |
|
Hansol Pns
KO:010420
|
0.036x |
|
Thai Film Industries Public Company Limited
BK:TFI
|
-0.044x |
|
B.M.P. PHARMA TRAD (BMP.SG)
STU:BMP
|
N/A |
|
PlumbFast Co. Ltd
KQ:035200
|
0.012x |
|
Renovaro Biosciences Inc
NASDAQ:RENB
|
0.085x |
|
Thai O.P.P. Public Company Limited
BK:TOPP
|
0.030x |
|
Damsan JSC
VN:ADS
|
0.181x |
Annual Cash Flow Conversion Efficiency for Nova EYE Medical Ltd (1992–2025)
The table below shows the annual cash flow conversion efficiency of Nova EYE Medical Ltd from 1992 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Nova EYE Medical Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$18.97 Million ≈ $13.42 Million |
AU$-6.15 Million ≈ $-4.35 Million |
-0.324x | +11.97% |
| 2024-06-30 | AU$21.33 Million ≈ $15.09 Million |
AU$-7.86 Million ≈ $-5.56 Million |
-0.368x | -27.10% |
| 2023-06-30 | AU$23.19 Million ≈ $16.41 Million |
AU$-6.72 Million ≈ $-4.76 Million |
-0.290x | -88.11% |
| 2022-06-30 | AU$30.40 Million ≈ $21.51 Million |
AU$-4.68 Million ≈ $-3.31 Million |
-0.154x | +58.58% |
| 2021-06-30 | AU$35.34 Million ≈ $25.00 Million |
AU$-13.14 Million ≈ $-9.30 Million |
-0.372x | -786.28% |
| 2020-06-30 | AU$100.59 Million ≈ $71.17 Million |
AU$5.45 Million ≈ $3.86 Million |
0.054x | +188.64% |
| 2019-06-30 | AU$68.80 Million ≈ $48.68 Million |
AU$-4.21 Million ≈ $-2.98 Million |
-0.061x | -958.05% |
| 2018-06-30 | AU$73.24 Million ≈ $51.82 Million |
AU$522.00K ≈ $369.35K |
0.007x | +111.61% |
| 2017-06-30 | AU$56.93 Million ≈ $40.28 Million |
AU$-3.50 Million ≈ $-2.47 Million |
-0.061x | -156.81% |
| 2016-06-30 | AU$48.26 Million ≈ $34.14 Million |
AU$5.22 Million ≈ $3.69 Million |
0.108x | -37.57% |
| 2015-06-30 | AU$39.79 Million ≈ $28.16 Million |
AU$6.89 Million ≈ $4.88 Million |
0.173x | +136.60% |
| 2014-06-30 | AU$36.95 Million ≈ $26.14 Million |
AU$2.70 Million ≈ $1.91 Million |
0.073x | +16.05% |
| 2013-06-30 | AU$30.83 Million ≈ $21.81 Million |
AU$1.94 Million ≈ $1.38 Million |
0.063x | +10.04% |
| 2012-06-30 | AU$32.06 Million ≈ $22.68 Million |
AU$1.84 Million ≈ $1.30 Million |
0.057x | +777.54% |
| 2011-06-30 | AU$30.32 Million ≈ $21.45 Million |
AU$198.00K ≈ $140.10K |
0.007x | -95.38% |
| 2010-06-30 | AU$33.19 Million ≈ $23.48 Million |
AU$4.69 Million ≈ $3.32 Million |
0.141x | +6.79% |
| 2009-06-30 | AU$30.05 Million ≈ $21.26 Million |
AU$3.98 Million ≈ $2.81 Million |
0.132x | +633.47% |
| 2008-06-30 | AU$47.94 Million ≈ $33.92 Million |
AU$-1.19 Million ≈ $-841.29K |
-0.025x | -155.72% |
| 2007-06-30 | AU$43.38 Million ≈ $30.69 Million |
AU$1.93 Million ≈ $1.37 Million |
0.045x | +79.61% |
| 2006-06-30 | AU$35.14 Million ≈ $24.87 Million |
AU$871.00K ≈ $616.29K |
0.025x | +124.26% |
| 2005-06-30 | AU$28.99 Million ≈ $20.51 Million |
AU$-2.96 Million ≈ $-2.10 Million |
-0.102x | -358.55% |
| 2004-06-30 | AU$30.48 Million ≈ $21.57 Million |
AU$1.20 Million ≈ $851.91K |
0.040x | -55.72% |
| 2003-06-30 | AU$30.59 Million ≈ $21.64 Million |
AU$2.73 Million ≈ $1.93 Million |
0.089x | +370.50% |
| 2002-06-30 | AU$30.81 Million ≈ $21.80 Million |
AU$-1.02 Million ≈ $-718.88K |
-0.033x | +94.34% |
| 2001-06-30 | AU$789.86K ≈ $558.88K |
AU$-460.00K ≈ $-325.48K |
-0.582x | -305.46% |
| 1997-06-30 | AU$1.64 Million ≈ $1.16 Million |
AU$-235.77K ≈ $-166.82K |
-0.144x | -8.88% |
| 1996-06-30 | AU$1.72 Million ≈ $1.21 Million |
AU$-226.28K ≈ $-160.11K |
-0.132x | -91.37% |
| 1995-06-30 | AU$1.20 Million ≈ $851.91K |
AU$-83.00K ≈ $-58.73K |
-0.069x | +84.18% |
| 1994-06-30 | AU$280.00K ≈ $198.12K |
AU$-122.00K ≈ $-86.32K |
-0.436x | +28.94% |
| 1993-06-30 | AU$486.00K ≈ $343.88K |
AU$-298.00K ≈ $-210.85K |
-0.613x | -15.03% |
| 1992-06-30 | AU$741.00K ≈ $524.30K |
AU$-395.00K ≈ $-279.49K |
-0.533x | -- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degen… Read more